Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

Chinese scientists have issued a warning about a new type of coronavirus called ‘NeoCov’, which is said to have a high death and transmission rate.
Russian news agency Sputnik reported that scientists from China’s Wuhan, where the Covid-19 virus was first discovered in 2019, have warned of ‘NeoCov’ in South Africa.
Associated with the MERS-CoV virus, the report however states that the ‘NeoCov’ virus is not new and it was discovered in outbreaks in Middle Eastern countries in 2012 and 2015 and is similar to the the SARS-CoV-2, which causes coronavirus in humans.
First found in a bat population in South Africa, the virus has only been known to spread among these animals. According to researchers from Wuhan University and the Chinese Academy of Sciences’ Institute of Biophysics, only one mutation is required for the virus to infiltrate human cells.
The research findings stated that the novel coronavirus poses a risk because it binds to the ACE2 receptor differently than the coronavirus pathogen. As a result, neither antibodies nor protein molecules produced by people with respiratory diseases or who have been immunised can protect against NeoCoV.
The Sputnik reported that following a briefing on NeoCoV, experts from the Russian State Virology and Biotechnology Research Center issued a statement on Thursday. The statement noted that the potential risks outlined by Wuhan scientists needed to be studied and probed further.

Wuhan scientists warn of deadlier coronavirus strain NeoCov: all we know so far

Chinese scientists warn about a new coronavirus, NeoCoV
Sputnik: NeoCov&nbsp;not new, first discovered in 2012 and 2015
NeoCov&nbsp;is associated with MERS-CoV&nbsp;and similar to SARS-CoV-2
NeoCoV&nbsp;was first detected in bats in South Africa
&nbsp;

Russian news agency Sputnik reported that scientists from China&rsquo;s Wuhan, where the Covid-19 virus was first discovered in 2019, have warned of &lsquo;NeoCov&rsquo; in South Africa.

Chinese scientists have issued a warning about a new type of coronavirus called &lsquo;NeoCov&rsquo;, which is said to have a high death and transmission rate.
Russian news agency Sputnik reported that scientists from China&rsquo;s Wuhan, where the Covid-19 virus was first discovered in 2019, have warned of &lsquo;NeoCov&rsquo; in South Africa.
Associated with the MERS-CoV virus, the report however states that the &lsquo;NeoCov&rsquo; virus is not new and it was discovered in outbreaks in Middle Eastern countries in 2012 and 2015 and is similar to the SARS-CoV-2, which causes coronavirus in humans.
First found in a bat population in South Africa, the virus has only been known to spread among these animals. According to researchers from Wuhan University and the Chinese Academy of Sciences&rsquo; Institute of Biophysics, only one mutation is required for the virus to infiltrate human cells.
The research findings stated that the novel coronavirus poses a risk because it binds to the ACE2 receptor differently than the coronavirus pathogen. As a result, neither antibodies nor protein molecules produced by people with respiratory diseases or who have been immunised can protect against NeoCoV.
The Sputnik reported that following a briefing on NeoCoV, experts from the Russian State Virology and Biotechnology Research Center issued a statement on Thursday. The statement noted that the potential risks outlined by Wuhan scientists needed to be studied and probed further.

neocov

Categories